|
covid-19 |
26 |
|
sars-cov-2 |
24 |
|
gastroenterology |
22 |
|
aspirin |
16 |
|
epidemiology |
16 |
|
medical sciences |
16 |
|
sars-cov |
16 |
|
colorectal cancer |
15 |
|
atrial fibrillation |
14 |
|
colonoscopy |
14 |
|
complications |
14 |
|
coronavirus infection |
14 |
|
health outcomes |
14 |
|
immune activation |
14 |
|
intestine |
14 |
|
replication |
14 |
|
gastrointestinal bleeding |
12 |
|
chemoprevention |
11 |
|
covid-19 vaccine |
11 |
|
gastric cancer |
11 |
|
helicobacter pylori |
11 |
|
autoimmune disorders |
10 |
|
gastrointestinal haemorrhage |
10 |
|
inflammatory bowel disease |
10 |
|
metformin |
10 |
|
time in therapeutic range |
10 |
|
adult |
8 |
|
antibiotics |
8 |
|
adenocarcinoma |
7 |
|
alkaline phosphatase |
7 |
|
biliary |
7 |
|
biomarker |
7 |
|
chinese |
7 |
|
cholangiogram |
7 |
|
cohort study |
7 |
|
colon cancer |
7 |
|
crc |
7 |
|
immortal time bias |
7 |
|
interval cancer |
7 |
|
ketamine |
7 |
|
magnetic resonance cholangiography |
7 |
|
mir-139-3p |
7 |
|
mir-622 |
7 |
|
mirna |
7 |
|
nonsteroidal anti-inflammatory drugs |
7 |
|
substance abuse |
7 |
|
type 2 diabetes mellitus |
7 |
|
colon neoplasms |
6 |
|
curative colectomy |
6 |
|
dabigatran |
6 |
|
follow up |
6 |
|
gastrointestinal tumours |
6 |
|
humans |
6 |
|
preventive medicine |
6 |
|
primary care |
6 |
|
recurrence |
6 |
|
rivaroxaban |
6 |
|
stomach cancer |
6 |
|
warfarin |
6 |
|
angiotensin-converting enzyme inhibitors |
5 |
|
anticoagulant |
5 |
|
bacteria |
5 |
|
bleeding |
5 |
|
cancer incidence |
5 |
|
cancer risk |
5 |
|
china |
5 |
|
clopidogrel |
5 |
|
cohort analysis |
5 |
|
colonic neoplasms |
5 |
|
comorbidity |
5 |
|
dyspepsia |
5 |
|
endoscopic retrograde cholangiopancreatography |
5 |
|
endoscopic sphicterotomy |
5 |
|
esomeprazole |
5 |
|
fecal-to-oral transmission |
5 |
|
gastroesophageal reflux |
5 |
|
gastrointestinal hemorrhage |
5 |
|
intestinal metaplasia |
5 |
|
methylation |
5 |
|
noncardiac chest pain |
5 |
|
non–vitamin k antagonist oral anticoagulants |
5 |
|
nsaid |
5 |
|
papillotomy |
5 |
|
post‐colonoscopy colorectal cancer |
5 |
|
prisma |
5 |
|
propensity score |
5 |
|
readmission |
5 |
|
real‐life |
5 |
|
renin |
5 |
|
sars |
5 |
|
stroke |
5 |
|
ulcerative colitis |
5 |
|
viral persistence |
5 |
|
13c-urea breath test |
4 |
|
adverse outcome |
4 |
|
ageaged |
4 |
|
antiplatelet |
4 |
|
antiplatelet drugs |
4 |
|
bioinformatics |
4 |
|
calcium channel blockers |
4 |
|
colorectal neoplasms |
4 |
|
colorectal polyp |
4 |
|
crc patients |
4 |
|
crohn's disease |
4 |
|
diagnostic biomarker |
4 |
|
drug use |
4 |
|
experimental design |
4 |
|
female |
4 |
|
gastric adenocarcinoma |
4 |
|
h pylori |
4 |
|
health economics |
4 |
|
helicobacter pylori - treatment |
4 |
|
helicobacterpylori |
4 |
|
hepatitis b |
4 |
|
latency interval |
4 |
|
male |
4 |
|
malignancy |
4 |
|
metagenomics |
4 |
|
microbiome |
4 |
|
micrornas - physiology |
4 |
|
middle aged |
4 |
|
nafld |
4 |
|
next generation sequencing |
4 |
|
nf-kappa b - physiology |
4 |
|
oral anticoagulant |
4 |
|
peptic ulcer |
4 |
|
pharmacoepidemiology |
4 |
|
ppi |
4 |
|
prevention |
4 |
|
proton pump inhibitors |
4 |
|
receptors, prostaglandin e, ep2 subtype - physiology |
4 |
|
receptors, prostaglandin e, ep4 subtype - physiology |
4 |
|
rectal cancer |
4 |
|
serum microrna (mirna) |
4 |
|
stomach |
4 |
|
stomach neoplasms - pathology |
4 |
|
surgery |
4 |
|
thiopurine |
4 |
|
thiopurines |
4 |
|
time trend |
4 |
|
vaccine |
4 |
|
adenocarcinoma - metabolism |
3 |
|
age |
3 |
|
artificial ventilation |
3 |
|
bungarotoxins - pharmacology |
3 |
|
cancer |
3 |
|
carcinogens - toxicity |
3 |
|
cell line, tumor |
3 |
|
cell proliferation - drug effects |
3 |
|
cerebrovascular accident |
3 |
|
coronavirus |
3 |
|
cox-2 |
3 |
|
cyclin d1 - metabolism |
3 |
|
cyclooxygenase 2 - drug effects - metabolism |
3 |
|
diagnosis |
3 |
|
dinoprostone - metabolism |
3 |
|
direct thrombin inhibitor |
3 |
|
drug side effect |
3 |
|
factor xa inhibitor |
3 |
|
gastric dysplasia |
3 |
|
gastroscopy |
3 |
|
gene expression regulation - drug effects |
3 |
|
h2ra |
3 |
|
healthcare dataset |
3 |
|
hong kong |
3 |
|
hospitalization |
3 |
|
infection |
3 |
|
lymph-node metastasis |
3 |
|
magnifying endoscopy |
3 |
|
nicotine |
3 |
|
nicotine - toxicity |
3 |
|
nicotinic acetylcholine receptor |
3 |
|
nitrosamines - toxicity |
3 |
|
nnk |
3 |
|
p38 mitogen-activated protein kinases - drug effects - metabolism |
3 |
|
propranolol - pharmacology |
3 |
|
receptors, adrenergic, beta - drug effects - metabolism |
3 |
|
receptors, nicotinic - drug effects - metabolism |
3 |
|
signal transduction - drug effects |
3 |
|
staging |
3 |
|
stomach neoplasms - metabolism |
3 |
|
β-adrenergic receptor |
3 |
|
2-cl-ib-meca |
2 |
|
5-ht |
2 |
|
adenoma - epidemiology |
2 |
|
adenosine a3 receptor |
2 |
|
adverse outcomes |
2 |
|
allied health personnel - standards |
2 |
|
animals |
2 |
|
animals, newborn |
2 |
|
antibiotic |
2 |
|
apixaban |
2 |
|
apoptosis - physiology |
2 |
|
aryl hydrocarbon receptor |
2 |
|
azathioprine |
2 |
|
balloon dilation |
2 |
|
c-fos |
2 |
|
capsule endoscopy |
2 |
|
chemopreventive agents |
2 |
|
china - epidemiology |
2 |
|
cholangitis - pathology |
2 |
|
colon - innervation - metabolism - physiopathology |
2 |
|
colonic polyps - epidemiology |
2 |
|
colorectal neoplasms - epidemiology |
2 |
|
consensus |
2 |
|
diabetes mellitus |
2 |
|
diarrhea - pathology - virology |
2 |
|
disease models, animal |
2 |
|
dtl/ramp |
2 |
|
edoxaban |
2 |
|
elderly-onset |
2 |
|
endoscopy |
2 |
|
endoscopy, gastrointestinal - methods |
2 |
|
enteritis - pathology - virology |
2 |
|
enterochromaffin-like cells |
2 |
|
fbln1 |
2 |
|
feces - virology |
2 |
|
follow-up |
2 |
|
gastric neoplasia |
2 |
|
gastrin |
2 |
|
gene expression |
2 |
|
gut microbiota |
2 |
|
h. pylori |
2 |
|
ibd |
2 |
|
immunohistochemistry |
2 |
|
irritable bowel syndrome - diagnosis - therapy |
2 |
|
irritable bowel syndrome - metabolism - physiopathology |
2 |
|
l2dtl |
2 |
|
low dose |
2 |
|
maternal deprivation |
2 |
|
medicine, chinese traditional - standards |
2 |
|
natural history |
2 |
|
neonatal maternal separation |
2 |
|
nf-kappa b |
2 |
|
novel anticoagulants |
2 |
|
nuclear proteins - genetics - metabolism |
2 |
|
observer variation |
2 |
|
oncogene |
2 |
|
p21 |
2 |
|
p53 |
2 |
|
pain threshold |
2 |
|
physical examination |
2 |
|
ppis |
2 |
|
pressure |
2 |
|
prevalence |
2 |
|
proto-oncogene proteins c-fos - metabolism |
2 |
|
proton pump inhibition |
2 |
|
proximal colonic cancer |
2 |
|
raphe nuclei - metabolism |
2 |
|
rats |
2 |
|
rats, sprague-dawley |
2 |
|
receptors, serotonin, 5-ht3 - genetics - metabolism |
2 |
|
reflex - physiology |
2 |
|
retrospective studies |
2 |
|
rna, viral - analysis |
2 |
|
sars virus - genetics - isolation & purification |
2 |
|
serotonin |
2 |
|
serotonin - metabolism |
2 |
|
serotonin plasma membrane transport proteins - genetics - metabolism |
2 |
|
serrated lesion |
2 |
|
sessile serrated adenoma/polyp |
2 |
|
severe acute respiratory syndrome - complications - pathology |
2 |
|
spinal cord - metabolism |
2 |
|
steroid-dependent ulcerative colitis |
2 |
|
stomach neoplasms - genetics - metabolism |
2 |
|
stress, psychological - metabolism - physiopathology |
2 |
|
surveillance |
2 |
|
treatment |
2 |
|
triple therapy |
2 |
|
tumor markers, biological - analysis |
2 |
|
tumour suppressor gene |
2 |
|
tumourigenesis |
2 |
|
visceral hyperalgesia |
2 |
|
2-pyridinylmethylsulfinylbenzimidazoles - administration & dosage - therapeutic use |
1 |
|
3' untranslated regions - genetics |
1 |
|
3′-untranslated region |
1 |
|
5- aminosalicylic acid |
1 |
|
abdominal pain - etiology |
1 |
|
abo blood-group system - genetics |
1 |
|
acid suppression |
1 |
|
actins - genetics - metabolism |
1 |
|
adalimumab |
1 |
|
adaptor proteins, signal transducing |
1 |
|
adenocarcinoma - blood - diagnosis - genetics |
1 |
|
adenocarcinoma - blood - metabolism - pathology |
1 |
|
adenocarcinoma - chemistry - metabolism - pathology |
1 |
|
adenocarcinoma - drug therapy - pathology |
1 |
|
adenocarcinoma - enzymology - genetics - pathology - surgery |
1 |
|
adenocarcinoma - enzymology - microbiology - pathology |
1 |
|
adenocarcinoma - genetics |
1 |
|
adenocarcinoma - genetics - metabolism |
1 |
|
adenocarcinoma - genetics - microbiology |
1 |
|
adenocarcinoma - microbiology |
1 |
|
adenocarcinoma - pathology - prevention & control |
1 |
|
adenoma |
1 |
|
adenoma - diagnosis |
1 |
|
adenoma - epidemiology - pathology |
1 |
|
adenoma - genetics - pathology |
1 |
|
adenoma detection rate |
1 |
|
adenosine triphosphatases |
1 |
|
adhesins, bacterial |
1 |
|
adolescent |
1 |
|
adriamycin |
1 |
|
age distribution |
1 |
|
age factors |
1 |
|
aged |
1 |
|
aged, 80 and over |
1 |
|
agranulocytosis |
1 |
|
agranulocytosis - chemically induced |
1 |
|
agriculture |
1 |
|
air |
1 |
|
alanine transaminase - blood |
1 |
|
alcohol drinking |
1 |
|
amino acid sequence |
1 |
|
amino acid substitution |
1 |
|
amoxicillin - administration & dosage - therapeutic use |
1 |
|
amoxicillin - therapeutic use |
1 |
|
ampicillin - administration & dosage |
1 |
|
analysis of variance |
1 |
|
anemia, iron-deficiency - etiology |
1 |
|
angiodysplasia - diagnosis |
1 |
|
angiogenesis |
1 |
|
angiogenesis inhibitors - pharmacology |
1 |
|
angiography |
1 |
|
angiopoietin |
1 |
|
angiopoietin-1 - genetics |
1 |
|
annexin a5 - pharmacology |
1 |
|
antacids - therapeutic use |
1 |
|
anti-bacterial agents - administration & dosage |
1 |
|
anti-bacterial agents - administration & dosage - therapeutic use |
1 |
|
anti-bacterial agents - pharmacology |
1 |
|
anti-bacterial agents - pharmacology - therapeutic use |
1 |
|
anti-bacterial agents - therapeutic use |
1 |
|
anti-hiv agents - therapeutic use |
1 |
|
anti-infective agents - administration & dosage |
1 |
|
anti-inflammatory agents |
1 |
|
anti-inflammatory agents, non-steroidal - administration & dosage - adverse effects - therapeutic use |
1 |
|
anti-inflammatory agents, non-steroidal - adverse effects |
1 |
|
anti-inflammatory agents, non-steroidal - adverse effects - therapeutic use |
1 |
|
anti-inflammatory agents, non-steroidal - pharmacology - therapeutic use |
1 |
|
anti-inflammatory agents, non-steroidal - therapeutic use |
1 |
|
anti-ulcer agents - administration & dosage |
1 |
|
anti-ulcer agents - administration & dosage - therapeutic use |
1 |
|
anti-ulcer agents - adverse effects - therapeutic use |
1 |
|
anti-ulcer agents - therapeutic use |
1 |
|
antibiotics, antineoplastic - pharmacology |
1 |
|
antibodies, antineutrophil cytoplasmic - analysis |
1 |
|
antibodies, bacterial - analysis |
1 |
|
antibodies, bacterial - blood |
1 |
|
antibodies, fungal - analysis |
1 |
|
antibodies, viral - diagnostic use |
1 |
|
antigens, bacterial |
1 |
|
antigens, bacterial - analysis |
1 |
|
antigens, bacterial - genetics |
1 |
|
antigens, bacterial - immunology |
1 |
|
antigens, cd34 - biosynthesis |
1 |
|
antigens, surface - genetics - metabolism |
1 |
|
antimetabolites, antineoplastic - pharmacology |
1 |
|
antineoplastic agents - administration & dosage |
1 |
|
antineoplastic agents - pharmacology |
1 |
|
antineoplastic agents - therapeutic use |
1 |
|
antiparasitic agents - therapeutic use |
1 |
|
antisense |
1 |
|
antiviral agents - therapeutic use |
1 |
|
apoptosis |
1 |
|
apoptosis - drug effects |
1 |
|
apoptosis - drug effects - genetics |
1 |
|
apoptosis regulatory proteins |
1 |
|
area under the curve |
1 |
|
arthritis - drug therapy |
1 |
|
artificial intelligence |
1 |
|
asia - epidemiology |
1 |
|
asia - ethnology |
1 |
|
asia, southeastern - epidemiology |
1 |
|
asian continental ancestry group |
1 |
|
aspirin - administration & dosage - adverse effects |
1 |
|
aspirin - adverse effects |
1 |
|
aspirin - adverse effects - therapeutic use |
1 |
|
atrophy |
1 |
|
au-rich element |
1 |
|
azacitidine |
1 |
|
azacitidine - pharmacology |
1 |
|
bacteraemia |
1 |
|
bacteremia - diagnosis - metabolism - microbiology |
1 |
|
bacteremia - drug therapy |
1 |
|
bacteremia - drug therapy - etiology - transmission |
1 |
|
bacterial proteins - genetics |
1 |
|
bacterial vaccines |
1 |
|
bacteriological techniques - statistics & numerical data |
1 |
|
base pair mismatch |
1 |
|
base pair mismatch - genetics |
1 |
|
base sequence |
1 |
|
bcl2 |
1 |
|
benzamides - administration & dosage - pharmacology |
1 |
|
benzodiazepines |
1 |
|
beta catenin |
1 |
|
biological markers - blood |
1 |
|
biologics |
1 |
|
biopsy |
1 |
|
biopsy, needle |
1 |
|
biosimilar |
1 |
|
bismuth - administration & dosage |
1 |
|
bismuth - administration & dosage - therapeutic use |
1 |
|
bismuth - therapeutic use |
1 |
|
bites, human |
1 |
|
bivalvia - microbiology |
1 |
|
blotting, southern |
1 |
|
blotting, western |
1 |
|
body mass index |
1 |
|
breath tests |
1 |
|
bromocriptine |
1 |
|
bromocriptine - therapeutic use |
1 |
|
buffers |
1 |
|
butanones - therapeutic use |
1 |
|
cadherins - biosynthesis - genetics - metabolism |
1 |
|
cadherins - genetics |
1 |
|
cadherins - genetics - metabolism |
1 |
|
cadherins - metabolism |
1 |
|
cadmium - pharmacology |
1 |
|
calcium-calmodulin-dependent protein kinases - genetics |
1 |
|
calcium-calmodulin-dependent protein kinases - metabolism |
1 |
|
caliciviridae infections - classification - epidemiology - genetics |
1 |
|
caliciviridae infections - epidemiology - transmission - virology |
1 |
|
caliciviridae infections - virology |
1 |
|
capsid |
1 |
|
capsule endoscopy - methods |
1 |
|
capsules |
1 |
|
carbon isotopes - diagnostic use |
1 |
|
carcinoma - enzymology |
1 |
|
carcinoma - epidemiology - pathology |
1 |
|
carcinoma - genetics |
1 |
|
carcinoma - genetics - pathology |
1 |
|
carcinoma, hepatocellular - blood supply - enzymology - virology |
1 |
|
carcinoma, hepatocellular - drug therapy - pathology |
1 |
|
carcinoma, hepatocellular - metabolism - pathology |
1 |
|
carcinoma, small cell |
1 |
|
cardiovascular diseases - prevention & control |
1 |
|
carrier proteins |
1 |
|
carrier proteins - biosynthesis - metabolism |
1 |
|
carrier proteins - genetics |
1 |
|
carrier proteins - genetics - metabolism |
1 |
|
case-control studies |
1 |
|
caspase 3 |
1 |
|
caspases - metabolism |
1 |
|
catalase |
1 |
|
catalase - metabolism |
1 |
|
catatonia - diagnosis - drug therapy - psychology |
1 |
|
ccl4 |
1 |
|
cecum |
1 |
|
ceftazidime - administration & dosage |
1 |
|
celecoxib |
1 |
|
cell culture techniques |
1 |
|
cell culture techniques - methods |
1 |
|
cell cycle |
1 |
|
cell cycle proteins |
1 |
|
cell division |
1 |
|
cell division - drug effects |
1 |
|
cell kinetics |
1 |
|
cell line |
1 |
|
cell proliferation |
1 |
|
cell transformation, neoplastic |
1 |
|
cell transformation, neoplastic - genetics |
1 |
|
cells, cultured |
1 |
|
chemicals and cas registry numbers |
1 |
|
chemokines - metabolism |
1 |
|
chemoprevention - methods |
1 |
|
chemotaxis |
1 |
|
chi-square distribution |
1 |
|
child |
1 |
|
child, preschool |
1 |
|
china - ethnology |
1 |
|
cholangiopancreatography, endoscopic retrograde - methods |
1 |
|
choledocholithiasis - complications - diagnosis |
1 |
|
cholestasis, extrahepatic - diagnosis - etiology |
1 |
|
cholesterol - blood |
1 |
|
choline deficiency |
1 |
|
chromatin remodeling |
1 |
|
chromatography, high pressure liquid |
1 |
|
chromosomal proteins, non-histone - biosynthesis |
1 |
|
chronic hepatitis b |
1 |
|
chronic ulcerative colitis |
1 |
|
cirrhosis |
1 |
|
cisplatin - therapeutic use |
1 |
|
clarithromycin |
1 |
|
clarithromycin - administration & dosage - therapeutic use |
1 |
|
clarithromycin - pharmacology |
1 |
|
clarithromycin - pharmacology - therapeutic use |
1 |
|
clarithromycin - therapeutic use |
1 |
|
clarithromycin-containing triple therapy |
1 |
|
clinical competence |
1 |
|
clinical outcomes |
1 |
|
clinical stool specimens |
1 |
|
clinical trials as topic |
1 |
|
clobetasol - adverse effects |
1 |
|
clostridium difficile |
1 |
|
cloxacillin |
1 |
|
cloxacillin - adverse effects |
1 |
|
cochrane library |
1 |
|
cohort studies |
1 |
|
colitis |
1 |
|
colitis, ulcerative |
1 |
|
colitis, ulcerative - complications - diagnosis - drug therapy - epidemiology - therapy |
1 |
|
colitis, ulcerative - complications - epidemiology - pathology - surgery |
1 |
|
colon - pathology |
1 |
|
colon cancer detection |
1 |
|
colonic neoplasms - diagnosis |
1 |
|
colonic polyps - diagnosis |
1 |
|
colonoscopes |
1 |
|
colonoscopy - adverse effects |
1 |
|
colonoscopy - methods |
1 |
|
colonoscopy - statistics & numerical data |
1 |
|
colorectal lesion |
1 |
|
colorectal neoplasms - complications - epidemiology - ethnology - pathology |
1 |
|
colorectal neoplasms - diagnosis |
1 |
|
colorectal neoplasms - diagnosis - enzymology |
1 |
|
colorectal neoplasms - diagnosis - ethnology |
1 |
|
colorectal neoplasms - epidemiology - mortality |
1 |
|
colorectal neoplasms - etiology |
1 |
|
colorectal neoplasms - genetics |
1 |
|
colorectal neoplasms - genetics - pathology |
1 |
|
colorectal neoplasms - pathology |
1 |
|
coloring agents |
1 |
|
combined modality therapy |
1 |
|
comet assay |
1 |
|
common bile duct |
1 |
|
comparison |
1 |
|
congresses as topic |
1 |
|
connective tissue growth factor |
1 |
|
cooking and eating utensils |
1 |
|
covid‐19 |
1 |
|
cpg islands |
1 |
|
crohn |
1 |
|
crohn disease |
1 |
|
crohn disease - classification - pathology - surgery |
1 |
|
crohn disease - complications - immunology |
1 |
|
cross-sectional studies |
1 |
|
culture |
1 |
|
culture media |
1 |
|
cyanoacrylates - diagnostic use |
1 |
|
cyclin d1 - analysis - biosynthesis |
1 |
|
cyclin d2 |
1 |
|
cyclin-dependent kinase inhibitor p15 |
1 |
|
cyclin-dependent kinase inhibitor p16 - metabolism |
1 |
|
cyclin-dependent kinase inhibitor p21 |
1 |
|
cyclin-dependent kinases - metabolism |
1 |
|
cyclins - biosynthesis |
1 |
|
cyclins - metabolism |
1 |
|
cyclo-oxygenase-2 |
1 |
|
cyclooxygenase 1 |
1 |
|
cyclooxygenase 2 |
1 |
|
cyclooxygenase 2 - analysis |
1 |
|
cyclooxygenase 2 - analysis - metabolism |
1 |
|
cyclooxygenase 2 - genetics |
1 |
|
cyclooxygenase 2 - genetics - metabolism |
1 |
|
cyclooxygenase 2 - genetics - metabolism - physiology |
1 |
|
cyclooxygenase 2 inhibitors |
1 |
|
cyclooxygenase 2 inhibitors - pharmacology |
1 |
|
cyclooxygenase 2 inhibitors - therapeutic use |
1 |
|
cyclooxygenase inhibitors - administration & dosage - therapeutic use |
1 |
|
cyclooxygenase inhibitors - adverse effects - therapeutic use |
1 |
|
cyclooxygenase inhibitors - pharmacology |
1 |
|
cyclooxygenase inhibitors - therapeutic use |
1 |
|
cyclooxygenase-2 |
1 |
|
cysteine endopeptidases - metabolism |
1 |
|
cysteine proteinase inhibitors - pharmacology |
1 |
|
cytokines - genetics |
1 |
|
cytokines - metabolism |
1 |
|
cytomegalovirus |
1 |
|
cytoskeletal proteins - analysis - biosynthesis |
1 |
|
cytoskeletal proteins - genetics - metabolism |
1 |
|
cytosol - metabolism |
1 |
|
data collection |
1 |
|
databases, nucleic acid |
1 |
|
deep learning |
1 |
|
definition |
1 |
|
delayed-action preparations |
1 |
|
delirium, dementia, amnestic, cognitive disorders - diagnosis - drug therapy - psychology |
1 |
|
demethylation |
1 |
|
detection |
1 |
|
diagnosis tumor |
1 |
|
diagnosis, differential |
1 |
|
diarrhea - drug therapy |
1 |
|
diarrhea - microbiology |
1 |
|
diarrhea - virology |
1 |
|
diclofenac - administration & dosage - adverse effects |
1 |
|
diclofenac - adverse effects - therapeutic use |
1 |
|
diet |
1 |
|
diet - adverse effects |
1 |
|
dimerization |
1 |
|
dinoprostone - analysis |
1 |
|
disease classification |
1 |
|
disease outbreaks |
1 |
|
disease progression |
1 |
|
disease-free survival |
1 |
|
diterpenes - pharmacology |
1 |
|
dna - analysis - genetics |
1 |
|
dna - chemistry - genetics |
1 |
|
dna - genetics |
1 |
|
dna - genetics - metabolism |
1 |
|
dna damage |
1 |
|
dna fragmentation |
1 |
|
dna methylation |
1 |
|
dna methylation - drug effects |
1 |
|
dna mutational analysis |
1 |
|
dna mutational analysis - methods |
1 |
|
dna primers |
1 |
|
dna primers - chemistry |
1 |
|
dna primers - genetics |
1 |
|
dna repair |
1 |
|
dna repair - genetics |
1 |
|
dna repair enzymes |
1 |
|
dna, antisense |
1 |
|
dna, antisense - genetics |
1 |
|
dna, bacterial - analysis |
1 |
|
dna, bacterial - analysis - isolation & purification |
1 |
|
dna, bacterial - genetics |
1 |
|
dna, bacterial - isolation & purification |
1 |
|
dna, complementary |
1 |
|
dna, complementary - isolation & purification |
1 |
|
dna, neoplasm - analysis |
1 |
|
dna, neoplasm - blood |
1 |
|
dna, neoplasm - blood - genetics |
1 |
|
dna, neoplasm - genetics - isolation & purification |
1 |
|
dna, ribosomal - analysis |
1 |
|
dna, viral - isolation & purification |
1 |
|
dna-binding proteins |
1 |
|
dna-binding proteins - analysis |
1 |
|
dna-binding proteins - genetics - metabolism |
1 |
|
dna-binding proteins - metabolism |
1 |
|
dna-binding proteins - pharmacology |
1 |
|
dopamine agonists - therapeutic use |
1 |
|
dose-response relationship, drug |
1 |
|
double-blind method |
1 |
|
down-regulation |
1 |
|
down-regulation - drug effects - genetics |
1 |
|
doxorubicin - pharmacology |
1 |
|
drug administration schedule |
1 |
|
drug combinations |
1 |
|
drug resistance, bacterial - genetics |
1 |
|
drug resistance, neoplasm - genetics - physiology |
1 |
|
drug therapy, combination |
1 |
|
drug therapy, combination - therapeutic use |
1 |
|
drug withdrawal |
1 |
|
drugs, chinese herbal |
1 |
|
drugs, chinese herbal - adverse effects |
1 |
|
drugs, chinese herbal - pharmacology |
1 |
|
duodenal ulcer - chemically induced - prevention & control |
1 |
|
duodenal ulcer - complications - epidemiology - pathology |
1 |
|
duodenal ulcer - drug therapy - etiology - microbiology |
1 |
|
duodenal ulcer - drug therapy - microbiology |
1 |
|
duodenum |
1 |
|
dyspepsia - chemically induced |
1 |
|
dyspepsia - diagnosis - drug therapy - psychology |
1 |
|
dyspepsia - drug therapy - etiology |
1 |
|
dyspepsia - epidemiology |
1 |
|
dyspepsia - etiology |
1 |
|
dyspepsia - microbiology |
1 |
|
e-cadherin |
1 |
|
e-cadherin-catenin |
1 |
|
early detection |
1 |
|
elderly-onset ibd |
1 |
|
electrophoresis |
1 |
|
electrophoresis, agar gel |
1 |
|
electrophoresis, polyacrylamide gel |
1 |
|
electrophoretic mobility shift assay |
1 |
|
endoscopes, gastrointestinal |
1 |
|
endoscopy, gastrointestinal |
1 |
|
endosonography - methods |
1 |
|
endothelial cells - cytology - drug effects - physiology |
1 |
|
enrichment |
1 |
|
enterobacteriaceae infections - complications |
1 |
|
enterocytes - virology |
1 |
|
enzyme activation - drug effects |
1 |
|
enzyme inhibitors - administration & dosage - therapeutic use |
1 |
|
enzyme inhibitors - pharmacology |
1 |
|
enzyme-linked immunosorbent assay |
1 |
|
enzyme-linked immunosorbent assay - methods |
1 |
|
epigenesis, genetic |
1 |
|
epigenetic |
1 |
|
epigenetic changes |
1 |
|
epithelial cells - drug effects - enzymology - pathology |
1 |
|
epithelial cells - pathology |
1 |
|
equipment design |
1 |
|
erythromycin |
1 |
|
erythromycin - pharmacology |
1 |
|
esophageal neoplasms - epidemiology |
1 |
|
esophagitis - diagnosis - microbiology |
1 |
|
esophagitis, peptic - complications - drug therapy - pathology - physiopathology |
1 |
|
esophagitis, peptic - microbiology - physiopathology |
1 |
|
esophagoscopy |
1 |
|
esophagus - physiopathology |
1 |
|
ethnic groups |
1 |
|
evaluation studies as topic |
1 |
|
exanthema - drug therapy |
1 |
|
eye proteins - genetics - metabolism |
1 |
|
false negative reactions |
1 |
|
false positive reactions |
1 |
|
family |
1 |
|
far east - epidemiology |
1 |
|
fas |
1 |
|
fas ligand protein |
1 |
|
fatal outcome |
1 |
|
fatty liver - blood - etiology - prevention & control |
1 |
|
feasibility studies |
1 |
|
feces |
1 |
|
feces - chemistry |
1 |
|
fibroblasts - cytology - metabolism |
1 |
|
flavonoids - pharmacology |
1 |
|
flow cytometry |
1 |
|
fluorescent dyes - pharmacology |
1 |
|
follow-up studies |
1 |
|
food microbiology |
1 |
|
foodborne diseases - drug therapy - etiology |
1 |
|
frizzled protein |
1 |
|
frizzled related protein |
1 |
|
g0 phase - drug effects |
1 |
|
g1 phase - drug effects |
1 |
|
gastrectomy |
1 |
|
gastric acid - secretion |
1 |
|
gastric cancer promoter hypermethylation |
1 |
|
gastric caner |
1 |
|
gastric carcinoma |
1 |
|
gastric mucosa |
1 |
|
gastric mucosa - cytology - metabolism |
1 |
|
gastric mucosa - drug effects - pathology |
1 |
|
gastric mucosa - enzymology - microbiology - pathology |
1 |
|
gastric mucosa - metabolism |
1 |
|
gastric mucosa - microbiology |
1 |
|
gastric mucosa - microbiology - pathology |
1 |
|
gastric mucosa - microbiology - physiology |
1 |
|
gastric mucosa - pathology |
1 |
|
gastric mucosa - pathology - secretion |
1 |
|
gastric mucosa - pathology - virology |
1 |
|
gastrins - blood |
1 |
|
gastritis |
1 |
|
gastritis - blood |
1 |
|
gastritis - complications - diagnosis - drug therapy |
1 |
|
gastritis - complications - epidemiology - microbiology |
1 |
|
gastritis - diagnosis - microbiology |
1 |
|
gastritis - diagnosis - microbiology - physiopathology |
1 |
|
gastritis - diagnosis - pathology |
1 |
|
gastritis - genetics - metabolism - microbiology |
1 |
|
gastritis - genetics - pathology |
1 |
|
gastritis - immunology - microbiology - prevention & control |
1 |
|
gastritis - microbiology - pathology |
1 |
|
gastritis - microbiology - physiopathology |
1 |
|
gastroenteritis - epidemiology - virology |
1 |
|
gastroenteritis - virology |
1 |
|
gastroesophageal reflux - complications - drug therapy - pathology - physiopathology |
1 |
|
gastroesophageal reflux - complications - epidemiology - microbiology |
1 |
|
gastroesophageal reflux - diagnosis - etiology - therapy |
1 |
|
gastroesophageal reflux - drug therapy - pathology |
1 |
|
gastroesophageal reflux - microbiology - physiopathology |
1 |
|
gastrointestinal diseases - diagnosis |
1 |
|
gastrointestinal diseases - epidemiology - microbiology |
1 |
|
gastrointestinal hemorrhage - chemically induced - complications - prevention & control |
1 |
|
gastrointestinal hemorrhage - chemically induced - prevention & control |
1 |
|
gastrointestinal hemorrhage - diagnosis |
1 |
|
gastrointestinal hemorrhage - diagnosis - etiology - pathology - radiography - therapy |
1 |
|
gastrointestinal hemorrhage - diagnosis - pathology |
1 |
|
gastrointestinal hemorrhage - diagnosis - radiography |
1 |
|
gastrointestinal hemorrhage - etiology |
1 |
|
gastrointestinal hemorrhage - pathology - prevention & control - therapy |
1 |
|
gastrointestinal neoplasms - drug therapy - pathology |
1 |
|
gastrointestinal transit |
1 |
|
gastrointestinal transit - drug effects - physiology |
1 |
|
gastroscopy - methods |
1 |
|
gene deletion |
1 |
|
gene expression - drug effects |
1 |
|
gene expression profiling |
1 |
|
gene expression regulation |
1 |
|
gene expression regulation, enzymologic - drug effects |
1 |
|
gene expression regulation, neoplastic |
1 |
|
gene expression regulation, neoplastic - drug effects |
1 |
|
gene silencing |
1 |
|
genes, dominant |
1 |
|
genes, p16 - genetics |
1 |
|
genes, tumor suppressor |
1 |
|
genes, tumor suppressor - physiology |
1 |
|
genes, viral |
1 |
|
genes, viral - genetics |
1 |
|
genetic markers |
1 |
|
genetic predisposition to disease |
1 |
|
genetic predisposition to disease - genetics |
1 |
|
genetic testing |
1 |
|
genetic testing - methods |
1 |
|
genetic vectors |
1 |
|
genome, viral |
1 |
|
genotype |
1 |
|
geoduck clam |
1 |
|
ghrelin |
1 |
|
glucocorticoids - adverse effects |
1 |
|
glutathione s-transferase pi |
1 |
|
glutathione transferase - genetics |
1 |
|
glutathione transferase - genetics - metabolism |
1 |
|
glutathione transferase - metabolism |
1 |
|
granuloma - complications |
1 |
|
green fluorescent proteins - genetics - metabolism |
1 |
|
growth substances - genetics - metabolism |
1 |
|
growth substances - metabolism |
1 |
|
guidance |
1 |
|
guidelines |
1 |
|
hbv infection |
1 |
|
helicobacter infections - blood |
1 |
|
helicobacter infections - complications |
1 |
|
helicobacter infections - complications - diagnosis - drug therapy |
1 |
|
helicobacter infections - complications - drug therapy |
1 |
|
helicobacter infections - complications - drug therapy - microbiology - pathology |
1 |
|
helicobacter infections - complications - drug therapy - pathology |
1 |
|
helicobacter infections - complications - epidemiology |
1 |
|
helicobacter infections - complications - epidemiology - transmission |
1 |
|
helicobacter infections - complications - microbiology |
1 |
|
helicobacter infections - complications - therapy |
1 |
|
helicobacter infections - diagnosis |
1 |
|
helicobacter infections - diagnosis - drug therapy |
1 |
|
helicobacter infections - diagnosis - enzymology - metabolism - microbiology |
1 |
|
helicobacter infections - diagnosis - epidemiology |
1 |
|
helicobacter infections - diagnosis - ethnology |
1 |
|
helicobacter infections - diagnosis - genetics |
1 |
|
helicobacter infections - diagnosis - metabolism - microbiology |
1 |
|
helicobacter infections - diagnosis - microbiology |
1 |
|
helicobacter infections - diagnosis - microbiology - physiopathology |
1 |
|
helicobacter infections - diagnosis - pathology |
1 |
|
helicobacter infections - drug therapy |
1 |
|
helicobacter infections - drug therapy - metabolism |
1 |
|
helicobacter infections - drug therapy - microbiology |
1 |
|
helicobacter infections - drug therapy - pathology |
1 |
|
helicobacter infections - drug therapy - pathology - prevention & control |
1 |
|
helicobacter infections - drug therapy - physiopathology |
1 |
|
helicobacter infections - enzymology - microbiology |
1 |
|
helicobacter infections - epidemiology |
1 |
|
helicobacter infections - epidemiology - microbiology |
1 |
|
helicobacter infections - genetics |
1 |
|
helicobacter infections - immunology - prevention & control |
1 |
|
helicobacter infections - metabolism |
1 |
|
helicobacter infections - microbiology - physiopathology |
1 |
|
helicobacter infections - microbiology - transmission |
1 |
|
helicobacter infections - pathology |
1 |
|
helicobacter infections - transmission |
1 |
|
helicobacter pylori - drug effects |
1 |
|
helicobacter pylori - drug effects - genetics |
1 |
|
helicobacter pylori - enzymology - isolation & purification - metabolism |
1 |
|
helicobacter pylori - genetics |
1 |
|
helicobacter pylori - genetics - growth & development - isolation & purification |
1 |
|
helicobacter pylori - genetics - isolation & purification |
1 |
|
helicobacter pylori - genetics - metabolism |
1 |
|
helicobacter pylori - growth & development - isolation & purification |
1 |
|
helicobacter pylori - immunology |
1 |
|
helicobacter pylori - immunology - isolation & purification |
1 |
|
helicobacter pylori - isolation & purification |
1 |
|
helicobacter pylori - isolation & purification - metabolism |
1 |
|
helicobacter pylori - pathogenicity |
1 |
|
helicobacter pylori - physiology |
1 |
|
helicobacter pylori sensitivity |
1 |
|
helicobacter pylori serology |
1 |
|
helicobacter pylori specificity |
1 |
|
hematemesis - etiology |
1 |
|
heme oxygenase (decyclizing) - metabolism |
1 |
|
heme oxygenase-1 |
1 |
|
hemin - pharmacology |
1 |
|
hemostatic techniques |
1 |
|
hepatic artery - injuries - surgery |
1 |
|
hepatic fibrosis |
1 |
|
hepatic stellate cell |
1 |
|
hepatitis |
1 |
|
hepatitis - mortality - pathology - virology |
1 |
|
hepatitis b - complications - mortality |
1 |
|
hepatitis b - transmission - virology |
1 |
|
hepatitis b - virology |
1 |
|
hepatitis b surface antigens - blood |
1 |
|
hepatitis b virus |
1 |
|
hepatitis b virus - classification - genetics - isolation & purification |
1 |
|
hepatitis b virus - isolation & purification |
1 |
|
hepatitis b, chronic - complications - drug therapy |
1 |
|
hepatitis b, chronic - complications - enzymology - pathology |
1 |
|
hepatitis b, chronic - drug therapy - metabolism - pathology |
1 |
|
hepatitis, animal - drug therapy - enzymology - pathology |
1 |
|
hepatocarcinogenesis |
1 |
|
hepatocytes - drug effects |
1 |
|
hepatocytes - enzymology |
1 |
|
herb-drug interactions |
1 |
|
herbal medicine |
1 |
|
heroin dependence - complications |
1 |
|
heteroduplex |
1 |
|
histocompatibility antigens - genetics |
1 |
|
homeodomain proteins - genetics |
1 |
|
homocysteine |
1 |
|
homocysteine - blood |
1 |
|
hong kong - epidemiology |
1 |
|
hospital mortality |
1 |
|
hox11 |
1 |
|
human bite |
1 |
|
human gastric cancer |
1 |
|
humoral immunity |
1 |
|
hydrogen-ion concentration |
1 |
|
hyperhomocysteinemia - complications |
1 |
|
hypermethylation |
1 |
|
hypnotics and sedatives - therapeutic use |
1 |
|
hypolipidemic agents - administration & dosage - pharmacology |
1 |
|
il-6 |
1 |
|
ileal diseases - diagnosis |
1 |
|
image processing, computer-assisted |
1 |
|
imidazoles - pharmacology |
1 |
|
immediate-early proteins - analysis - metabolism |
1 |
|
immunization - methods |
1 |
|
immunoblotting |
1 |
|
immunoblotting - standards |
1 |
|
immunoenzyme techniques |
1 |
|
immunosuppressive agents - therapeutic use |
1 |
|
in situ hybridization |
1 |
|
in situ hybridization, fluorescence |
1 |
|
in situ nick-end labeling |
1 |
|
incidence |
1 |
|
indomethacin |
1 |
|
indomethacin - pharmacology |
1 |
|
indomethacin - therapeutic use |
1 |
|
infant |
1 |
|
infant, newborn |
1 |
|
infectious disease transmission, vertical |
1 |
|
inflammatory bowel diseases |
1 |
|
infliximab |
1 |
|
inhibitor of apoptosis proteins |
1 |
|
insufflation |
1 |
|
intercellular adhesion molecule-1 - genetics - metabolism |
1 |
|
intercellular signaling peptides and proteins - analysis - metabolism |
1 |
|
intercellular signaling peptides and proteins - genetics - metabolism |
1 |
|
interferons - therapeutic use |
1 |
|
interleukin-6 - genetics - metabolism |
1 |
|
interleukin-6 - pharmacology |
1 |
|
interleukins - genetics |
1 |
|
interobserver variation |
1 |
|
intestinal diseases - chemically induced - pathology |
1 |
|
intestinal diseases - complications |
1 |
|
intestinal diseases - diagnosis |
1 |
|
intestinal mucosa - virology |
1 |
|
intestinal neoplasms |
1 |
|
intestinal neoplasms - pathology |
1 |
|
intestinal neoplasms - secondary |
1 |
|
intestinal polyps - diagnosis - enzymology |
1 |
|
intestinal trefoil factor |
1 |
|
intestine, small |
1 |
|
intestine, small - drug effects - physiology |
1 |
|
intestine, small - pathology |
1 |
|
intestine, small - pathology - radiography |
1 |
|
intestine, small - radiography |
1 |
|
intestines - microbiology - pathology |
1 |
|
intestines - pathology |
1 |
|
intracellular signaling peptides and proteins |
1 |
|
intracellular signaling peptides and proteins - blood - metabolism |
1 |
|
intubation |
1 |
|
invasion |
1 |
|
investigation |
1 |
|
irritable bowel syndrome - drug therapy |
1 |
|
ischemic heart disease |
1 |
|
isoenzymes - analysis |
1 |
|
isoenzymes - antagonists & inhibitors |
1 |
|
isoenzymes - biosynthesis |
1 |
|
isoenzymes - biosynthesis - genetics |
1 |
|
isoenzymes - genetics |
1 |
|
isoenzymes - genetics - metabolism |
1 |
|
isoenzymes - metabolism |
1 |
|
israel - epidemiology |
1 |
|
itf |
1 |
|
ivermectin - therapeutic use |
1 |
|
janus kinase 1 |
1 |
|
jaundice - diagnosis |
1 |
|
kinetics |
1 |
|
kruppel-like |
1 |
|
kruppel-like transcription factors - genetics - metabolism |
1 |
|
kynurenine |
1 |
|
lactones - administration & dosage |
1 |
|
lamivudine - therapeutic use |
1 |
|
large bowel |
1 |
|
lethal catatonia |
1 |
|
leukapheresis - methods |
1 |
|
life style |
1 |
|
ligands |
1 |
|
lipogenesis - genetics |
1 |
|
lipoprotein lipase - genetics - metabolism |
1 |
|
lipoproteins, hdl - blood |
1 |
|
liver - drug effects - metabolism - pathology |
1 |
|
liver - enzymology - pathology |
1 |
|
liver - pathology - virology |
1 |
|
liver cirrhosis - complications |
1 |
|
liver cirrhosis - metabolism - pathology |
1 |
|
liver cirrhosis, experimental - drug therapy - pathology |
1 |
|
liver diseases - metabolism - pathology |
1 |
|
liver fibrosis |
1 |
|
liver function tests |
1 |
|
liver neoplasms - blood supply - enzymology - virology |
1 |
|
liver neoplasms - drug therapy - pathology |
1 |
|
liver neoplasms - metabolism - pathology |
1 |
|
logistic models |
1 |
|
longitudinal studies |
1 |
|
lorazepam - therapeutic use |
1 |
|
loss of heterozygosity |
1 |
|
low resource countries |
1 |
|
lower gastrointestinal bleeding |
1 |
|
lung - virology |
1 |
|
lung metastasis |
1 |
|
lymphocytes - physiology |
1 |
|
macrophages - physiology |
1 |
|
magnetic resonance imaging |
1 |
|
magnetic resonance imaging - adverse effects - methods |
1 |
|
mass screening - economics - methods - statistics & numerical data |
1 |
|
mass screening - methods |
1 |
|
mass screening - statistics & numerical data |
1 |
|
matrix metalloproteinase 9 - genetics - metabolism |
1 |
|
matrix metalloproteinases - analysis - metabolism |
1 |
|
medicine, chinese traditional |
1 |
|
melena - diagnosis - radiography |
1 |
|
membrane glycoproteins - metabolism |
1 |
|
membrane proteins |
1 |
|
membrane proteins - genetics - metabolism |
1 |
|
metaplasia |
1 |
|
metaplasia - drug therapy - pathology |
1 |
|
metaplasia - etiology - pathology - therapy |
1 |
|
metaplasia - genetics |
1 |
|
metaplasia - metabolism |
1 |
|
metaplasia - microbiology |
1 |
|
metaplasia - microbiology - pathology |
1 |
|
methionine - deficiency |
1 |
|
methylnitronitrosoguanidine |
1 |
|
methylnitronitrosoguanidine - toxicity |
1 |
|
methylnitrosourea - toxicity |
1 |
|
metronidazole - administration & dosage |
1 |
|
metronidazole - pharmacology |
1 |
|
metronidazole - therapeutic use |
1 |
|
mice |
1 |
|
mice, inbred balb c |
1 |
|
mice, inbred c57bl |
1 |
|
mice, nude |
1 |
|
mice, transgenic |
1 |
|
microbial sensitivity tests |
1 |
|
microbiological techniques - standards |
1 |
|
microcirculation |
1 |
|
microsatellite instability |
1 |
|
microsatellite repeats |
1 |
|
microsatellite repeats - genetics |
1 |
|
microscopy, fluorescence |
1 |
|
microtubule-associated proteins |
1 |
|
miniaturization |
1 |
|
misoprostol - administration & dosage |
1 |
|
mitochondria - metabolism |
1 |
|
mitogen-activated protein kinases - antagonists & inhibitors - metabolism |
1 |
|
mlh1 |
1 |
|
mmp-9 |
1 |
|
models, animal |
1 |
|
models, biological |
1 |
|
molecular sequence data |
1 |
|
montreal classification |
1 |
|
moraxellaceae infections - drug therapy - etiology - transmission |
1 |
|
mucins |
1 |
|
mucins - genetics - metabolism |
1 |
|
muscle proteins |
1 |
|
muscle proteins - genetics - metabolism |
1 |
|
mutation |
1 |
|
mutation - genetics |
1 |
|
mutation, missense |
1 |
|
muts |
1 |
|
muts homolog 2 protein |
1 |
|
myocardial ischemia - etiology |
1 |
|
naproxen - administration & dosage |
1 |
|
naproxen - adverse effects - therapeutic use |
1 |
|
neoplasm |
1 |
|
neoplasm invasiveness |
1 |
|
neoplasm metastasis |
1 |
|
neoplasm proteins |
1 |
|
neoplasm proteins - analysis |
1 |
|
neoplasm proteins - genetics |
1 |
|
neoplasm proteins - genetics - metabolism |
1 |
|
neoplasm proteins - metabolism |
1 |
|
neoplasm proteins - physiology |
1 |
|
neoplasm staging |
1 |
|
neoplasm transplantation |
1 |
|
neovascularization, pathologic |
1 |
|
neovascularization, pathologic - genetics - metabolism - prevention & control |
1 |
|
neovascularization, pathologic - pathology |
1 |
|
neovascularization, physiologic - drug effects |
1 |
|
nerve tissue proteins - biosynthesis |
1 |
|
neuropeptides |
1 |
|
neuropeptides - genetics - metabolism |
1 |
|
nf-kappa b - metabolism |
1 |
|
nitrobenzenes - pharmacology |
1 |
|
non-steroidal |
1 |
|
norovirus - classification - pathogenicity |
1 |
|
norovirus - genetics - isolation & purification |
1 |
|
norovirus - growth & development |
1 |
|
norovirus - growth & development - physiology |
1 |
|
nuclear proteins |
1 |
|
nuclear proteins - biosynthesis - drug effects - genetics |
1 |
|
nuclear receptor coactivators |
1 |
|
occult blood |
1 |
|
oligonucleotide |
1 |
|
oligonucleotide array sequence analysis |
1 |
|
omeprazole - administration & dosage - adverse effects |
1 |
|
omeprazole - administration & dosage - therapeutic use |
1 |
|
omeprazole - adverse effects - therapeutic use |
1 |
|
omeprazole - therapeutic use |
1 |
|
oncogenes |
1 |
|
oncogenes - physiology |
1 |
|
organic chemicals |
1 |
|
organometallic compounds - administration & dosage |
1 |
|
organometallic compounds - therapeutic use |
1 |
|
organophosphorus compounds - administration & dosage - pharmacology |
1 |
|
osteoarthritis - drug therapy |
1 |
|
oviducts - enzymology |
1 |
|
p15 |
1 |
|
p16 |
1 |
|
p53 gene |
1 |
|
patient care team |
1 |
|
patient satisfaction |
1 |
|
pedigree |
1 |
|
penicillins - administration & dosage - therapeutic use |
1 |
|
penicillins - adverse effects |
1 |
|
penicillins - therapeutic use |
1 |
|
peptic ulcer - chemically induced - etiology - prevention & control |
1 |
|
peptic ulcer - chemically induced - prevention & control |
1 |
|
peptic ulcer - complications |
1 |
|
peptic ulcer - complications - diagnosis - drug therapy |
1 |
|
peptic ulcer - diagnosis - microbiology |
1 |
|
peptic ulcer - diagnosis - pathology |
1 |
|
peptic ulcer - drug therapy - microbiology |
1 |
|
peptic ulcer - drug therapy - microbiology - physiopathology |
1 |
|
peptic ulcer - microbiology - surgery |
1 |
|
peptic ulcer hemorrhage - chemically induced - prevention & control |
1 |
|
peptic ulcer hemorrhage - chemically induced - prevention & control - therapy |
1 |
|
peptic ulcer hemorrhage - diagnosis - microbiology |
1 |
|
peptic ulcer hemorrhage - drug therapy |
1 |
|
peptic ulcer hemorrhage - etiology - prevention & control |
1 |
|
peptic ulcer hemorrhage - microbiology |
1 |
|
peptic ulcer hemorrhage - mortality - surgery |
1 |
|
peptide hormones - physiology |
1 |
|
peptide mapping |
1 |
|
peptides - genetics - metabolism |
1 |
|
perforation |
1 |
|
perianal crohn’s disease |
1 |
|
peroxisome proliferator-activated receptors |
1 |
|
peroxisome proliferators activated receptor |
1 |
|
personal protective equipment |
1 |
|
phenanthrenes - pharmacology |
1 |
|
phenanthrolines - adverse effects |
1 |
|
phenotype |
1 |
|
phylogeny |
1 |
|
pilot projects |
1 |
|
placebos |
1 |
|
plant extracts |
1 |
|
plasmids |
1 |
|
plasmids - genetics |
1 |
|
plasmids - metabolism |
1 |
|
platelet aggregation inhibitors - adverse effects - therapeutic use |
1 |
|
point mutation |
1 |
|
polymerase chain reaction |
1 |
|
polymerase chain reaction - methods |
1 |
|
polymorphism, genetic |
1 |
|
polymorphism, restriction fragment length |
1 |
|
polymorphism, single-stranded conformational |
1 |
|
polyp |
1 |
|
polyps |
1 |
|
polyps - diagnosis - pathology - surgery |
1 |
|
population surveillance |
1 |
|
population surveillance - methods |
1 |
|
postoperative period |
1 |
|
ppar gamma - analysis - antagonists & inhibitors - genetics |
1 |
|
ppar gamma - genetics |
1 |
|
ppar gamma - genetics - metabolism |
1 |
|
practice guidelines as topic |
1 |
|
prb degradation |
1 |
|
precancerous conditions - diagnosis - pathology |
1 |
|
precancerous conditions - enzymology - microbiology - pathology |
1 |
|
precancerous conditions - epidemiology - pathology |
1 |
|
precancerous conditions - etiology - prevention & control |
1 |
|
precancerous conditions - genetics - pathology |
1 |
|
precancerous conditions - genetics - pathology - virology |
1 |
|
precancerous conditions - metabolism - pathology |
1 |
|
precancerous conditions - microbiology - pathology |
1 |
|
precipitin tests |
1 |
|
predictive value of tests |
1 |
|
probability |
1 |
|
prognosis |
1 |
|
prokinetic |
1 |
|
proliferating cell nuclear antigen - analysis |
1 |
|
promoter regions, genetic |
1 |
|
promoter regions, genetic - drug effects - physiology |
1 |
|
promoter regions, genetic - genetics |
1 |
|
proportional hazards models |
1 |
|
prospective studies |
1 |
|
prostaglandin d2 - analogs & derivatives - pharmacology |
1 |
|
prostaglandin-endoperoxide synthases |
1 |
|
prostaglandin-endoperoxide synthases - analysis |
1 |
|
prostaglandin-endoperoxide synthases - biosynthesis |
1 |
|
prostaglandin-endoperoxide synthases - biosynthesis - genetics |
1 |
|
prostaglandin-endoperoxide synthases - genetics |
1 |
|
prostaglandin-endoperoxide synthases - genetics - metabolism |
1 |
|
prostaglandin-endoperoxide synthases - metabolism |
1 |
|
proteasome endopeptidase complex - metabolism |
1 |
|
protective agents |
1 |
|
protein array analysis |
1 |
|
protein-tyrosine kinases - pharmacology |
1 |
|
proteins - genetics - metabolism |
1 |
|
proteins - metabolism |
1 |
|
proteomics - methods |
1 |
|
proto-oncogene |
1 |
|
proto-oncogene proteins - analysis |
1 |
|
proto-oncogene proteins - genetics |
1 |
|
proto-oncogene proteins - genetics - metabolism |
1 |
|
proton pumps - antagonists & inhibitors |
1 |
|
proton pumps - pharmacology |
1 |
|
pseudopregnancy - enzymology |
1 |
|
psychrobacter |
1 |
|
psychrobacter - isolation & purification - pathogenicity |
1 |
|
pyloric antrum - chemistry |
1 |
|
pyloric antrum - microbiology - pathology |
1 |
|
pyloric antrum - pathology |
1 |
|
pyrazoles |
1 |
|
pyrazoles - adverse effects - therapeutic use |
1 |
|
pyrazoles - pharmacology |
1 |
|
pyrazoles - therapeutic use |
1 |
|
pyridines - pharmacology |
1 |
|
quality of life |
1 |
|
radiography, abdominal |
1 |
|
random allocation |
1 |
|
ranitidine - administration & dosage |
1 |
|
ranitidine - administration & dosage - analogs & derivatives - therapeutic use |
1 |
|
ranitidine - analogs & derivatives - therapeutic use |
1 |
|
rapid urease test |
1 |
|
rats, wistar |
1 |
|
reagent kits, diagnostic |
1 |
|
real-time rt-pcr |
1 |
|
recombinant fusion proteins - genetics - metabolism |
1 |
|
recurrence - prevention & control |
1 |
|
references (29) view in table layout |
1 |
|
registries |
1 |
|
regression analysis |
1 |
|
relatives |
1 |
|
repetitive sequences, nucleic acid |
1 |
|
repressor proteins - biosynthesis - metabolism |
1 |
|
repressor proteins - blood - metabolism |
1 |
|
reproducibility of results |
1 |
|
research design |
1 |
|
resistance |
1 |
|
retinoblastoma protein - metabolism - physiology |
1 |
|
reverse transcriptase polymerase chain reaction |
1 |
|
reverse transcriptase polymerase chain reaction - methods |
1 |
|
risk assessment |
1 |
|
risk factor |
1 |
|
risk factors |
1 |
|
rna interference |
1 |
|
rna replicase - genetics |
1 |
|
rna, messenger - analysis |
1 |
|
rna, messenger - analysis - biosynthesis |
1 |
|
rna, messenger - biosynthesis |
1 |
|
rna, messenger - chemistry |
1 |
|
rna, messenger - genetics |
1 |
|
rna, messenger - genetics - metabolism |
1 |
|
rna, messenger - metabolism |
1 |
|
rna, neoplasm - analysis |
1 |
|
rna, neoplasm - genetics |
1 |
|
rna, ribosomal, 16s - genetics |
1 |
|
rna, ribosomal, 23s - genetics |
1 |
|
rna, small interfering - genetics |
1 |
|
rna, viral - genetics |
1 |
|
rna-binding proteins - genetics - metabolism |
1 |
|
rnai |
1 |
|
roc curve |
1 |
|
rosiglitazone |
1 |
|
rural health |
1 |
|
saccharomyces cerevisiae - immunology |
1 |
|
safety |
1 |
|
salicylates - adverse effects |
1 |
|
saliva |
1 |
|
saliva - microbiology |
1 |
|
saliva - virology |
1 |
|
salmonella typhimurium |
1 |
|
salmonella typhimurium - enzymology - genetics - immunology |
1 |
|
sapovirus |
1 |
|
sapovirus - classification - genetics - isolation & purification |
1 |
|
sars virus - immunology |
1 |
|
seafood - microbiology |
1 |
|
self medication |
1 |
|
sensitivity and specificity |
1 |
|
septicaemia |
1 |
|
sequence alignment |
1 |
|
sequence analysis, dna |
1 |
|
sequence analysis, dna - methods |
1 |
|
serrated polyps |
1 |
|
serum albumin - pharmacology |
1 |
|
severe acute respiratory syndrome - complications - mortality |
1 |
|
severe acute respiratory syndrome - complications - mortality - pathology |
1 |
|
severe acute respiratory syndrome - virology |
1 |
|
severity of illness index |
1 |
|
sex distribution |
1 |
|
sex factors |
1 |
|
sfrps |
1 |
|
sigmoidoscopy - adverse effects |
1 |
|
signal transduction |
1 |
|
signal transduction - physiology |
1 |
|
singapore - epidemiology |
1 |
|
single-blind method |
1 |
|
smoking |
1 |
|
smoking - adverse effects |
1 |
|
socs-1 |
1 |
|
sodium chloride |
1 |
|
sodium chloride, dietary - toxicity |
1 |
|
somatic mutation |
1 |
|
sonication |
1 |
|
specialization |
1 |
|
species index: mus |
1 |
|
species specificity |
1 |
|
spem |
1 |
|
standardized incidence ratio |
1 |
|
staphylococcal infections - drug therapy |
1 |
|
staphylococcus aureus |
1 |
|
stat3 |
1 |
|
stat3 transcription factor |
1 |
|
statin |
1 |
|
statistics, nonparametric |
1 |
|
stomach - drug effects - physiology |
1 |
|
stomach - metabolism - pathology |
1 |
|
stomach - microbiology |
1 |
|
stomach - microbiology - pathology |
1 |
|
stomach - pathology |
1 |
|
stomach neoplasms - blood - diagnosis - genetics |
1 |
|
stomach neoplasms - blood - genetics - metabolism |
1 |
|
stomach neoplasms - blood - metabolism - pathology |
1 |
|
stomach neoplasms - blood supply - pathology |
1 |
|
stomach neoplasms - chemically induced - enzymology - genetics - pathology |
1 |
|
stomach neoplasms - chemistry - metabolism |
1 |
|
stomach neoplasms - chemistry - metabolism - pathology |
1 |
|
stomach neoplasms - complications - genetics - pathology |
1 |
|
stomach neoplasms - diagnosis - epidemiology - mortality |
1 |
|
stomach neoplasms - diagnosis - genetics |
1 |
|
stomach neoplasms - diagnosis - pathology |
1 |
|
stomach neoplasms - drug therapy - genetics - pathology |
1 |
|
stomach neoplasms - drug therapy - metabolism |
1 |
|
stomach neoplasms - drug therapy - pathology |
1 |
|
stomach neoplasms - enzymology |
1 |
|
stomach neoplasms - enzymology - genetics - metabolism - pathology |
1 |
|
stomach neoplasms - enzymology - genetics - pathology |
1 |
|
stomach neoplasms - enzymology - genetics - pathology - surgery |
1 |
|
stomach neoplasms - enzymology - microbiology - pathology |
1 |
|
stomach neoplasms - epidemiology |
1 |
|
stomach neoplasms - epidemiology - pathology |
1 |
|
stomach neoplasms - etiology |
1 |
|
stomach neoplasms - etiology - microbiology - prevention & control |
1 |
|
stomach neoplasms - etiology - prevention & control |
1 |
|
stomach neoplasms - genetics |
1 |
|
stomach neoplasms - genetics - metabolism - pathology |
1 |
|
stomach neoplasms - genetics - microbiology |
1 |
|
stomach neoplasms - genetics - pathology |
1 |
|
stomach neoplasms - genetics - pathology - virology |
1 |
|
stomach neoplasms - genetics - physiopathology |
1 |
|
stomach neoplasms - metabolism - microbiology - pathology |
1 |
|
stomach neoplasms - metabolism - pathology |
1 |
|
stomach neoplasms - microbiology |
1 |
|
stomach neoplasms - microbiology - pathology - prevention & control |
1 |
|
stomach neoplasms - pathology - prevention & control |
1 |
|
stomach neoplasms - pathology - therapy |
1 |
|
stomach neoplasms - prevention & control |
1 |
|
stomach ulcer - chemically induced - prevention & control |
1 |
|
stomach ulcer - complications - epidemiology - pathology |
1 |
|
stomach ulcer - drug therapy - etiology - microbiology |
1 |
|
stomach ulcer - etiology - pathology |
1 |
|
stomach ulcer - prevention & control - therapy |
1 |
|
strongyloides stercoralis |
1 |
|
strongyloidiasis |
1 |
|
strongyloidiasis - complications - diagnosis - drug therapy |
1 |
|
sucralfate - therapeutic use |
1 |
|
sudden infant death - etiology |
1 |
|
sulfites - chemistry |
1 |
|
sulfonamides - administration & dosage - therapeutic use |
1 |
|
sulfonamides - adverse effects - therapeutic use |
1 |
|
sulfonamides - pharmacology |
1 |
|
sulfonamides - therapeutic use |
1 |
|
sulfones - administration & dosage |
1 |
|
suppressor of cytokine signaling proteins |
1 |
|
survival analysis |
1 |
|
survival rate |
1 |
|
survivin |
1 |
|
t-cell acute lymphoblastic leukemia |
1 |
|
tetracycline - administration & dosage |
1 |
|
tetracycline - therapeutic use |
1 |
|
thiazolidinediones - pharmacology |
1 |
|
thiazolidinediones - pharmacology - therapeutic use |
1 |
|
thiobarbituric acid reactive substances - metabolism |
1 |
|
ticlopidine - analogs & derivatives - therapeutic use |
1 |
|
time factors |
1 |
|
timp-1 |
1 |
|
tissue inhibitor of metalloproteinase-1 - genetics - metabolism |
1 |
|
trans-activators |
1 |
|
trans-activators - biosynthesis - genetics |
1 |
|
trans-activators - genetics - metabolism |
1 |
|
trans-activators - pharmacology |
1 |
|
transcription factors - agonists - physiology |
1 |
|
transcription factors - genetics |
1 |
|
transcription factors - genetics - metabolism |
1 |
|
transcription factors - metabolism |
1 |
|
transcription, genetic |
1 |
|
transfection |
1 |
|
transforming growth factor beta - genetics |
1 |
|
transmission |
1 |
|
treatment failure |
1 |
|
treatment outcome |
1 |
|
trefoil peptides |
1 |
|
tumor |
1 |
|
tumor cells, cultured |
1 |
|
tumor cells, cultured - drug effects |
1 |
|
tumor markers, biological - blood |
1 |
|
tumor necrosis factor-alpha - genetics |
1 |
|
tumor necrosis factor-alpha - genetics - metabolism |
1 |
|
tumor suppressor protein p53 - genetics |
1 |
|
tumor suppressor protein p53 - metabolism - physiology |
1 |
|
tumor suppressor proteins |
1 |
|
tumour suppressor genes |
1 |
|
ulcer bleeding |
1 |
|
ulcerative |
1 |
|
up-regulation |
1 |
|
up-regulation - drug effects |
1 |
|
urea - analysis |
1 |
|
urea - diagnostic use |
1 |
|
urea - metabolism |
1 |
|
urease - analysis |
1 |
|
urease - blood |
1 |
|
urease - metabolism |
1 |
|
vagotomy |
1 |
|
vascular endothelial growth factor a - biosynthesis |
1 |
|
vascular endothelial growth factor a - metabolism |
1 |
|
vascular endothelial growth factors - metabolism |
1 |
|
vascular fistula - etiology - surgery |
1 |
|
video recording - instrumentation |
1 |
|
vienna classification |
1 |
|
viral plaque assay |
1 |
|
viral structural proteins - immunology - metabolism |
1 |
|
viral tropism |
1 |
|
virulence factors - metabolism |
1 |
|
virus replication |
1 |
|
virus shedding |
1 |
|
vitamins |
1 |
|
vomiting - microbiology |
1 |
|
warfarin - adverse effects - therapeutic use |
1 |
|
wgo |
1 |
|
wound healing |
1 |
|
x protein of hepatitis b virus |
1 |
|
young adult |
1 |
|
β-catenin |
1 |
